Emerging Trends in Synthetic Drugs Workshop Presentation Slides

April 30, 2013

WELCOME AND OPENING REMARKS

• John Paul Jones II, Program Manager, Law Enforcement Standards Program (OLES), National Institute of Standards and Technology (NIST)
• Jeff Comparin, Laboratory Director, Special Testing & Research Laboratory, Drug Enforcement Administration (DEA)
• Scott Oulton, Chair of Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG) & Associate Deputy Assistant Administrator, Office of Forensic Sciences, DEA

EMERGING TRENDS IN SYNTHETIC CANNABINOIDS AND SUBSTITUTE CATHINONES

Overview of the Problem (Will Not Be Webcast or Captioned)

• Bob Bell, Supervisory Special Agent, Office of Diversion Control, DEA

FEDERAL EMERGING TRENDS

Classes and Structures of Emerging Drugs

• Arthur Berrier, PhD, Senior Research Chemist, Special Testing & Research Laboratory, DEA

Novel Hallucinogens and Plant-Derived Highs

• Emily Dye, Forensic Chemist, Special Testing & Research Laboratory, DEA

Control Scheduling and Pending Legislation(Will Not Be Webcast or Captioned)

• Terry Boos, Chemist, Office of Diversion Control, DEA

Moderated by Shannan Williams, Associate (Contractor), OLES, NIST

INTERNATIONAL EMERGING TRENDS

New Drugs in the European Union

• Andrew Cunningham, Scientific Analyst, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal

STATE AND LOCAL EMERGING TRENDS - PART ONE

Synthetic Structures, State Legislation, Brand Names, Novel Approaches to Analysis, and How Analytical Results are Reported

• Jim Wesley, Drug Chemistry Supervisor, Monroe County, New York Crime Laboratory
• John Przybylski, Controlled Substances Section Supervisor, Virginia Department of Forensic Science
• Joseph Graves, Crime Lab Analyst Supervisor, Drug Chemistry Florida Department of Law Enforcement
• Moderated by Anthony Tambasco, Forensic Scientist/Laboratory Director, Mansfield, Ohio Police Department Crime Laboratory

PHARMACOLOGY OF SYNTHETIC DRUGS

• Marilyn A. Huestis, PhD, Chief, Chemistry and Drug Metabolism, Clinical Pharmacology and Therapeutic Research Branch, National Institutes of Health Biomedical Research Center

TOXICOLOGICAL ASPECTS OF SYNTHETIC DRUGS

• Barry Logan, PhD, Executive Director, Center for Forensic Science Research and Education, National Medical Services

May 1, 2013

OPENING REMARKS AND CAPABILITIES FOR MEASUREMENTS, MATERIALS, DATA MODELING, AND INFORMATION PROCESSING IN THE CHEMICAL SCIENCES DIVISION

• John Paul Jones II, Program Manager, OLES, NIST
• William MacCrehan, Research Chemist, Chemical Sciences Division (CSD), NIST

IDENTIFICATION AND STANDARDS

Criteria for Identification of Synthetic Drugs

• Scott Oulton, Chair of SWGDRUG & Associate Deputy Assistant Administrator, Office of Forensic Sciences, DEA

SWGDRUG Proposed Recommendation on Analogues and Structural Class Determinations

• Linda Jackson, Vice Chair of SWGDRUG & Director, Virginia Department of Forensic Science

Validation/Authentication of Physical Standards

• Nicole Astor, Chemistry Technical Leader, Division of Forensic Sciences, Georgia Bureau of Investigation

Authentication of Physical Standards

• Roxanne Franckowski, Senior Forensic Chemist, Special Testing & Research Laboratory, DEA

Moderated by John Paul Jones II, Program Manager, OLES, NIST

COLLABORATIVE EFFORTS

Live Demo of Online Database Resources for the Identification of Novel and Emerging Trends

• Peter R. Stout, PhD, Senior Research Forensic Scientist, Research Triangle Institute (RTI) International

Advisory Committee for the Evaluation of Controlled Substances Analogs

• Lindsay Reinhold, Forensic Chemist IV, National Medical Services

Moderated by Karen Phinney, Group Leader, Bioanalytical Science, NIST

STATE AND LOCAL EMERGING TRENDS - PART TWO

Synthetic Structures, State Legislation, Brand Names, Novel Approaches to Analysis, and How Analytical Results are Reported

• Anthony Tambasco, Forensic Scientist/Laboratory Director, Mansfield, Ohio Police Department Crime Laboratory
• Sandra Sachs, Criminalist III, Oakland Police Department Crime Laboratory
• Roger Schneider, Forensic Scientist Supervisor, Phoenix Police Department Laboratory Services Bureau

Moderated by Shannan Williams, Associate (Contractor), OLES, NIST

LABORATORY ANALYTICAL TECHNIQUES

Color Tests and Analytical Difficulties with Emerging Drugs of Abuse

• Jeremy Morris, Johnson County, Missouri Crime Laboratory

Statistical Sampling Approaches for Synthetic Drugs

• Jill Head, Supervisory Chemist, Special Testing & Research Laboratory, DEA

Interpretation and Potential Pitfalls of Analysis

• Josh Yohannan, Forensic Chemist, Special Testing & Research Laboratory, DEA

DEA Dosing Studies

• Elizabeth Guest, PhD, Forensic Chemist, Special Testing & Research Laboratory, DEA

Moderated by William MacCrehan, Research Chemist, CSD, NIST

CLOSING REMARKS

John Paul Jones II, Program Manager, OLES, NIST